Neuren Pharmaceuticals | NEU - Ebitda

Stock Price
12.71
Daily Change
0.47 3.84%
Monthly
-26.74%
Yearly
-2.53%
Q1 Forecast
12.80

Neuren Pharmaceuticals reported AUD176.7M in EBITDA for its fiscal semester ending in December of 2024.





Ebitda Change Date
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Avita Medical AUD -21.9M 12.04M Jun/2025
Clinuvel Pharmaceuticals AUD 27.55M 12.65M Jun/2025
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Genetic Signatures AUD -7.11M 970K Dec/2024
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
Medical Developments International AUD 1.78M 3.78M Dec/2024
Neuren Pharmaceuticals AUD 176.7M 166.79M Dec/2024
Organon & Co USD 383M 135M Dec/2025
Paradigm Biopharmaceuticals AUD -5.86M 3.79M Dec/2024
PYC Therapeutics AUD -24.29M 1.3M Jun/2025
Starpharma Holdings AUD -4.85M 1.73M Dec/2024
Tectonic Therapeutic USD -13.48M 5.73M Dec/2024
Telix Pharmaceuticals AUD 18.42M 14.82M Dec/2025
Viatris USD 1.15B 75.8M Sep/2025
Xeris Pharmaceuticals USD 17.42M 8.83M Sep/2025